0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13559381 2024-09-01 2025-08-31 13559381 2025-08-31 13559381 2024-08-31 13559381 2023-09-01 2024-08-31 13559381 2024-08-31 13559381 2023-08-31 13559381 bus:Director1 2024-09-01 2025-08-31 13559381 core:WithinOneYear 2025-08-31 13559381 core:WithinOneYear 2024-08-31 13559381 core:ShareCapital 2025-08-31 13559381 core:ShareCapital 2024-08-31 13559381 core:RetainedEarningsAccumulatedLosses 2025-08-31 13559381 core:RetainedEarningsAccumulatedLosses 2024-08-31 13559381 bus:SmallEntities 2024-09-01 2025-08-31 13559381 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 13559381 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 13559381 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13559381 bus:FullAccounts 2024-09-01 2025-08-31
COMPANY REGISTRATION NUMBER: 13559381

Dermavival Clinic Limited

Filleted Unaudited Financial Statements

31 August 2025

Dermavival Clinic Limited

Statement of Financial Position

31 August 2025

| 2025 | 2024
Note | £ | £ | £

Current assets

Stocks | 85 |  | –

Creditors: amounts falling due within one year | 4 | 2,199 |  | 1,482
| ------- |  | -------
Net current liabilities |  | 2,114 | 1,482
|  | ------- | -------
Total assets less current liabilities |  | ( 2,114) | ( 1,482)
|  | ------- | -------
Net liabilities |  | ( 2,114) | ( 1,482)
|  | ------- | -------

Capital and reserves

Called up share capital |  | 1 | 1
Profit and loss account |  | ( 2,115) | ( 1,483)
|  | ------- | -------
Shareholders deficit |  | ( 2,114) | ( 1,482)
|  | ------- | -------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 17 August 2026 , and are signed on behalf of the board by:

Mrs Z Morritt |
Director |

Company registration number: 13559381

Dermavival Clinic Limited

Notes to the Financial Statements

Year ended 31 August 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lyndhurst, 1 Cranmer Street, Long Eaton, Nottingham, NG10 1NJ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
In accordance with her responsibilities the director has considered the appropriateness of the going concern basis for the preparation of the financial statements. In forming her view, she has considered a period of at least 12 months from the date of approval of the financial statements. The company has a deficiency of assets as at 31 August 2025. It depends on the support of the director. The director considers it appropriate to prepare the financial statements on a going concern basis.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 47 | 20
Other creditors | 2,152 | 1,462
| ------- | -------
| 2,199 | 1,482
| ------- | -------

5. Director's advances, credits and guarantees
The amount owed to the director at the year end was £892 (2024: £1,462). The director's loan is interest free and repayable on demand.